The AQUARIUS study shows that Tekturna/Rasilez (aliskiren), from Novartis, neither improves nor slows the progression of coronary atherosclerosis when given...
The ELIXA Phase IIIb study designed to assess the cardiovascular (CV) safety of Lyxumia (lixisenatide), from Sanofi, in adults with...
The treatment of insulin dependent diabetes mellitus. May be used for diabetics who require an insulin of prompt onset and short duration. It is a suitable preparation for admixture with longer acting insulins. It is particularly useful where intermittent, short term or emergency therapy is required, during initial stabilisation and in the treatment of labile diabetes.
Exact Imaging has received FDA 510(k) Clearance for its ExactVu micro-ultrasound system. The ExactVu micro-ultrasound recently received CE marking enabling...
Explore the methods for bleeding risk management associated with vitamin K antagonists and non-vitamin K anticoagulants including congress presentations.
Background: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels.
Royal Philips announced it has received 510(k) clearance from the FDA to market ProxiDiagnost N90, its latest Digital Radiography-Fluoroscopy (DRF)...